Clinical Trials in Minneapolis

Showing 3561-3580 of 12,418 trials

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

NCT03687242

This is a Phase 2 study of SPR001 for the treatment of classic CAH that will provide 12 weeks of open-label treatment to eligible subjects.

Congenital Adrenal HyperplasiaCAH - Congenital Adrenal HyperplasiaCAH - 21-Hydroxylase Deficiency

Spruce Biosciences11 participantsStarted Sep 2018

Orange, California, United States • San Diego, California, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDNA< 1 mile

Effects of Virtual Reality Exercise on Promoting Physical Activity and Health Among College Students

NCT06902727

The purpose of this research is to examine the effectiveness of a 4-week immersive-virtual reality (VR) exercise bike intervention on college students' physiological outcomes (physical activity levels, cardiovascular fitness, and body composition) and psychological outcomes (situational motivation, situational interest, mood states, and depressive symptoms).

Physical Activity LevelsCardiovascular FitnessBody Composition+4 more

The University of Tennessee, Knoxville36 participantsStarted Sep 2020

Minneapolis, Minnesota, United States

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

Effects of Virtual Reality Exercise on Promoting Physical Activity and Health Among College Students

Find Trials by Condition in Minneapolis

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease

A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

MIP Versus PCNL for Kidney Stone Disease

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension